Cartesian Therapeutics
RNAC· Manufacturing· Fiscal year ends in December
Carsten Brunn, Ph.D. is the CEO of Cartesian Therapeutics and was paid $4.3M in FY2025 (Dec), down 41%.
Executives5
See all- 1Carsten Brunn, Ph.D.President and Chief Executive OfficerFY2025
- 2Metin Kurtoglu, M.D., Ph.D.Former Chief Technology OfficerFY2025
- 3Christopher Jewell, Ph.D.Former Chief Scientific OfficerFY2025
- 4Blaine DavisChief Financial OfficerFY2025
- 5Milos Miljkovic, M.D.Chief Medical OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allCartesian Therapeutics paid its 5 named executives $12.4M in total in FY2025 (Dec). CEO Carsten Brunn, Ph.D. was paid $4.3M of that.
| Name | |||
|---|---|---|---|
| Carsten Brunn, Ph.D.President and Chief Executive Officer | |||
| Metin Kurtoglu, M.D., Ph.D.Former Chief Technology Officer | |||
| Christopher Jewell, Ph.D.Former Chief Scientific Officer | |||
| Blaine DavisChief Financial Officer | |||
| Milos Miljkovic, M.D.Chief Medical Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See allThe FY2025 (Dec) proxy of Cartesian Therapeutics names 19 peer companies for pay. Among Cartesian Therapeutics and these peers, CEO pay was 6th highest of 12 and total shareholder return was 10th highest of 12.
6th highest of 12in Cartesian Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
10th highest of 12in Cartesian Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-2'%20d='M18.156,40.577.011,29.356l0-18.125L18.147,0'%20transform='translate(-0.004%20-0.001)'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-3'%20d='M35.133,14.327H26.354l4.389-7.163L35.127,0l4.395,7.164,4.389,7.163Z'%20transform='translate(-16.985)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-4'%20d='M51.052,93.782l0-8.211,18.178-3.019Z'%20transform='translate(-32.9%20-53.206)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-5'%20d='M69.213,11.223l-9.4,3.1L51.035,0Z'%20transform='translate(-32.892%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-6'%20d='M.01,11.23l9.387,3.1L18.148,0Z'%20transform='translate(-0.006%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-7'%20d='M75.741,34.672l9.4-3.1,0,18.125Z'%20transform='translate(-48.815%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-8'%20d='M9.406,34.672l-9.4-3.1,0,18.125Z'%20transform='translate(-0.004%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-9'%20d='M18.15,93.786l.016-8.209L0,82.56Z'%20transform='translate(0%20-53.21)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-10'%20d='M59.826,40.3,51.047,58.34l18.178-3.019Z'%20transform='translate(-32.9%20-25.974)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-11'%20d='M9.393,40.3l8.773,18.041L0,55.321Z'%20transform='translate(0%20-25.971)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-12'%20d='M35.174,40.3H26.418l4.367,9.019,4.4,9.027,4.373-9.027,4.389-9.02Z'%20transform='translate(-17.026%20-25.974)'%20fill='%238fd4e2'/%3e%3c/svg%3e)
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Mar 9, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 28, 2025 | FY2024 |
| Annual report | 10-K | Mar 13, 2025 | FY2024 |
| Annual report | 10-K | Mar 7, 2024 | FY2023 |
| Proxy statement | DEF 14A | Feb 14, 2024 | — |
